SCHEMBL862097

SCHEMBL862097

COc1cc(O)c2c(c1)O[C@H](c1ccc(OC)c(O)c1)[C@H](O)C2

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.68
▸ MAPK1 P28482 2/20 0.68
▸ BACE1 P56817 5/20 0.62
▸ KDM4E B2RXH2 5/20 0.62
▸ PTGS1 P23219 4/20 0.62
▸ GAA P10253 3/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ HSD17B10 Q99714 3/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ MAPT P10636 3/20 0.62
▸ APEX1 P27695 3/20 0.62
▸ RECQL P46063 3/20 0.62
▸ PKM P14618 2/20 0.62
▸ ALPL P05186 2/20 0.62
▸ POLB P06746 2/20 0.62
▸ PTGS2 P35354 2/20 0.62
▸ HPGD P15428 2/20 0.62
▸ ALOX15 P16050 2/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975181 1.00 CYP3A4 (0.68) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL1973504 0.93 CYP3A4 (0.80) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL862195 0.92 CYP3A4 (0.67) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL14284455 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL17778592 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL13099975 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL18685719 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL30217505 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL862094 0.91 KDM4E (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1
SCHEMBL348595 0.91 BACE1 (0.74) CYP3A4MAPK1BACE1KDM4EPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143308-B2 Synthesis of oligo/poly(catechins) and methods of use UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2012-03-27 — — US disclosed
US-20090170928-A1 Synthesis of oligo/poly(catechins) and methods of use GOVERNMENT OF THE UNITED STATES 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170928-A1 Synthesis of oligo/poly(catechins) and methods of use POLI, PUF60, FABP3 CYP3A4 1162/4885MAPK1 1507/4885BACE1 4807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback